title: CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice.
abstract: The present study was undertaken to understand the role of vaccine candidates PhtD and PhtE in pneumococcal nasopharyngeal (NP) colonization, their ability to induce CD4 T cell memory and antibody responses following primary NP colonization, and their contribution to protection against secondary pneumococcal colonization in mice. The study was also aimed at understanding the potential of immunization with PhtD and PhtE in eliciting qualitative CD4 T cell memory responses and protection against pneumococcal NP colonization in mice. PhtD and PhtE isogenic mutants in a TIGR4 background (TIGR4 ΔPhtD and TIGR4 ΔPhtE) were constructed and found to have a significantly reduced colonization density over time in the nasopharynges of mice compared to those of mice colonized with wild-type TIGR4. Mice with primary colonization by wild-type TIGR4, TIGR4 ΔPhtD, or TIGR4 ΔPhtE were protected against secondary colonization by wild-type TIGR4; nonetheless, the clearance of secondary colonization was slower in mice with primary colonization by either TIGR4 ΔPhtD or TIGR4 ΔPhtE than in mice with primary colonization by wild-type TIGR4. Colonization was found to be an immunizing event for PhtD and PhtE antigens (antibody response); however, we failed to detect any antigen (PhtD or PhtE)-specific CD4 T cell responses in any of the colonized groups of mice. Intranasal immunization with either PhtD or PhtE protein generated robust serum antibody and CD4 Th1-biased immune memory and conferred protection against pneumococcal colonization in mice. We conclude that PhtD and PhtE show promise as components in next-generation pneumococcal vaccine formulations.
authors.affiliation: Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
authors.forename: M N
authors.initials: MN
authors.lastname: Khan
authors.forename: M E
authors.initials: ME
authors.lastname: Pichichero
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology*; D002353:Carrier State; D007156:Immunologic Memory / Q000502:physiology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009666:Nose / Q000382:microbiology*; D010614:Pharynx / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
chemical_list: D000907:Antibodies, Bacterial; D001426:Bacterial Proteins
references.citation: PLoS Med. 2005 Jan;2(1):e15
references.pmid: 15696204
references.citation: Vaccine. 2012 Apr 16;30(18):2900-7
references.pmid: 22349524
references.citation: Lancet Infect Dis. 2004 Mar;4(3):144-54
references.pmid: 14998500
references.citation: PLoS Pathog. 2011 Dec;7(12):e1002396
references.pmid: 22144893
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4848-53
references.pmid: 15781870
references.citation: Microbiology (Reading). 2006 Feb;152(Pt 2):351-359
references.pmid: 16436423
references.citation: Microbiology (Reading). 2011 Feb;157(Pt 2):336-348
references.pmid: 20966093
references.citation: J Mol Biol. 1998 Nov 27;284(2):449-61
references.pmid: 9813129
references.citation: J Infect Dis. 2010 Jan 1;201(1):32-41
references.pmid: 19947881
references.citation: PLoS Pathog. 2008 Sep 19;4(9):e1000159
references.pmid: 18802458
references.citation: Vaccine. 2006 Sep 11;24(37-39):6225-31
references.pmid: 16797798
references.citation: Infect Immun. 2001 Feb;69(2):949-58
references.pmid: 11159990
references.citation: J Infect Dis. 2000 Oct;182(4):1146-52
references.pmid: 10979911
references.citation: JAMA. 2006 Apr 12;295(14):1668-74
references.pmid: 16609088
references.citation: J Clin Microbiol. 2007 Mar;45(3):948-52
references.pmid: 17202280
references.citation: Infect Immun. 2008 Jun;76(6):2767-76
references.pmid: 18391008
references.citation: Pediatr Infect Dis J. 2011 Aug;30(8):645-50
references.pmid: 21487325
references.citation: PLoS Pathog. 2013 Mar;9(3):e1003274
references.pmid: 23555269
references.citation: Vaccine. 2000 Feb 25;18(16):1707-11
references.pmid: 10689153
references.citation: Mol Microbiol. 1997 Sep;25(5):819-29
references.pmid: 9364908
references.citation: Curr Opin Immunol. 2011 Jun;23(3):407-13
references.pmid: 21514128
references.citation: Crit Rev Microbiol. 2008;34(3-4):163-73
references.pmid: 18819028
references.citation: Eur J Immunol. 2006 Jan;36(1):46-57
references.pmid: 16342325
references.citation: Infect Immun. 2011 Jan;79(1):238-45
references.pmid: 20956575
references.citation: Nat Immunol. 2011 Jun;12(6):509-17
references.pmid: 21739679
references.citation: Clin Vaccine Immunol. 2009 Jun;16(6):916-23
references.pmid: 19403781
references.citation: J Exp Med. 2002 Feb 4;195(3):359-65
references.pmid: 11828011
references.citation: Vaccine. 2007 Mar 1;25(11):2036-42
references.pmid: 17240006
references.citation: Cytometry A. 2008 Nov;73(11):984-91
references.pmid: 18612990
references.citation: Am J Respir Crit Care Med. 2013 Apr 15;187(8):855-64
references.pmid: 23370916
references.citation: Clin Microbiol Rev. 2006 Jul;19(3):571-82
references.pmid: 16847087
references.citation: Microbiol Mol Biol Rev. 2001 Jun;65(2):187-207 ; first page, table of contents
references.pmid: 11381099
references.citation: Immunobiology. 2010 Apr;215(4):251-63
references.pmid: 20071053
references.citation: Nat Rev Immunol. 2002 Apr;2(4):251-62
references.pmid: 12001996